On the Value of Measuring Recent Drug Use by Self-Reports and Urinalysis in Clinical Trials-Reference-Cited by-同舟云学术

On the Value of Measuring Recent Drug Use by Self-Reports and Urinalysis in Clinical Trials

Published:2024-09-12 Issue: Volume: Page:1-4
ISSN:1082-6084
Container-title:Substance Use & Misuse
language:en
Short-container-title:Substance Use & Misuse

Author:

Wish Eric D.¹^ORCID,Billing Amy S.¹^ORCID,Massey Ebonie¹,Cole Thomas²^ORCID,Greenblatt Aaron²^ORCID,Weintraub Eric²^ORCID,Dohlman Priya¹^ORCID,Belcher Annabelle²^ORCID

Affiliation:

1. CESAR: Center for Substance Use, Addiction & Health Research, University of Maryland, College Park, Maryland, USA

2. Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, USA

Funder

University of Maryland Strategic Partnership: MPowering the State: The Opioid Use Disorders Project

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/10826084.2024.2401341

Reference24 articles.

1. Criterion Validity of Self-Reports of Alcohol, Cannabis, and Methamphetamine Use Among Young Men in Cape Town, South Africa

2. Open-label dose-extending placebos for opioid use disorder: a protocol for a randomised controlled clinical trial with methadone treatment

3. Effectiveness of Conditioned Open-label Placebo With Methadone in Treatment of Opioid Use Disorder

4. Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study

5. Cary, P. L. (2006). The marijuana detection window: Determining the length of time cannabinoids will remain detectable in urine following smoking: A critical review of relevant research and cannabinoid detection guidance for drug courts. National Drug Court Institute.